Curate Biosciences Competitors and Similar CompaniesClear all
Astellas Gene Therapies's competitors and similar companies include Denali Therapeutics, Futura Genetics and Orchard Therapeutics.
 Astellas Gene Therapies Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. | |||
Founding Date | Founding Date 2013 | Founding Date 2015 | Founding Date 2014 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations San Francisco, US HQ | Locations South San Francisco, US HQ | Locations Tel Aviv-Yafo, IL HQ Coquitlam, CA | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US |
Employees | Employees 4091% increase | Employees 26146% increase | Employees 5 | Employees 166 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.8 b | Valuation ($) N/A | Valuation ($) 380.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $330.5m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) |
Net income | Net income ($128.8m) (FY, 2018) | Net income ($145.2m) (FY, 2023) | Net income N/A | Net income ($150.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised $ 180m | Total funding raised $ 424.4m | Total funding raised N/A | Total funding raised $ 310.7m |
For sources of this data, please see the company profile
View Company Profiles
Denali Therapeutics
HQ
South San Francisco, US
Employees
261↑ 46% increase
Denali Therapeutics is a biotechnology company.
View company
Futura Genetics
HQ
Tel Aviv-Yafo, IL
Employees
5
Futura Genetics specializes in lifestyle and healthcare genetic testing.
View companyOrchard Therapeutics
HQ
London, GB
Employees
166
Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders.
View company